Tacrolimus and mycophenolate mofetil provide effective immunosuppression in rat laryngeal transplantation

Laryngoscope

Volumn 113, Issue 8, 2003, Pages 1308-1313

  Nelson, Marc ^a   Fritz, Michael ^a   Dan, Olivia ^a   Worley, Sarah ^a   Strome, Marshall ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Immunosuppression; Laryngeal transplantation; Mycophenolate mofetil; Tacrolimus (FK506)

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LARYNX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSPLANTATION; WILCOXON SIGNED RANKS TEST;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GRAFT REJECTION; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LARYNX; MALE; MYCOPHENOLIC ACID; RATS; RATS, INBRED LEW; RATS, INBRED STRAINS; TACROLIMUS;

EID: 0042624847     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200308000-00009     Document Type: Article

References (29)

1. Suthanthiran M, Strom T. Immunobiology and immunopharmacology of organ allograft rejection. J Clin Immunol 1995;15:161-171.
2. Oyer P, Stinson E, Jamieson S, et al. Cyclosporine-A in cardiac allografting: a preliminary experience. Transplant Proc 1983;15:1247-1252.
3. Brayman KL, Egidi FM, Naji A, et al. Renal transplantation at the University of Pennsylvania Medical Center: an update of results in the cyclosporine era. Clin Transplant 1992:215-225.
4. Mayer A, Dmitrewski J, Squiffiet J, et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group, Transplantation 1997;64:436-443.
5. U.S. Multicenter Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994;331:1110-1115.
6. Peters D, Fitton A, Plosker G, Faulds D. Tacrolimus: a review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. Drugs 1993;46:746-794.
7. Ashan N, Johnson C, Gonwa T, et al. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. Transplantation 2001;72:245-250.
8. Eckoff D, McGuire B, Frenette L, et al. Tacrolimus (FK506) and mycophenolate mofetil combination therapy vs. tacrolimus in adult liver transplantation. Transplantation 1998;65:180-187.
9. Hunt S. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus. Cardiol Rev 2000;8:180-184.
10. Reichenspurner H, Kur F, Treede H, et al. Optimization of an immunosuppressive protocol after lung transplantation. Transplantation 1999;68:67-71.
11. Strome M, Stein J, Esclamado R, et al. Laryngeal transplantation and 40-month follow-up. N Engl J Med 2001;344:1676-1679.
12. Strome S, Sloman-Moll E, Samonte BR, Wu J, Strome M. Rat model for a vascularized laryngeal allograft. Ann Otol Rhinol Laryngol 1992;101:950-953.
13. Lorenz R, Dan O, Fritz M, et al. Rat laryngeal transplant model: technical advancements and a redefined rejection grading system. Ann Otol Rhinol Laryngol 2002;111:1120-1127.
14. Griffith B, Bando K, Hardesty R, et al. A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. Transplantation 1994;57:848-851.
15. Pirsch J, Miller J, Deierhoi M, et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997;63:977-983.
16. Meiser B, Ubarfiihr P, Fuchs A, et al. Is tacrolimus (FK506) superior to cyclosporine for primary immunosuppression after heart transplantation? J Am Coll Cardiol 1997;29(Suppl A):61-62.
17. Squifflet J, Backman L, Claesson K, et al. Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients. Transplantation 2001;72:63-69.
18. Taylor D, Ensley R, Olsen S, et al. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation. J Heart Lung Transplant 1994;13:571-582.
19. Cole O, Rigg K, Shehata M. The effect of different immunosuppressants on alloantigen dependent and independent factors involved in the development of chronic rejection in an animal model. Ann R Coll Surg Engl 2001;83:235-243.
20. Yoshida S, Toyama Y, Aoki T, et al. Combination therapy with FK506 and RS61443 for rejection following allogeneic small bowel transplantation in rats. Transplant Proc 2000;32:2492-2493.
21. Jones N, Hebebrand D, Buttemeyer R, et al. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: implications for clinical composite tissue transplantation. Plast Reconstr Surg 2001;107:777-784.
22. Land W, Schneeberger H, Weiss M, Ege T, Stumpfig L. Mycophenolate mofetil monotherapy: an optimal, safe, and efficacious immunosuppressive maintenance regimen in kidney transplant patients. Transplant Proc 2001;33(Suppl 4A):29S-35S.
23. Schlitt H, Barkmann A, Boker K, et al. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver transplant patients with renal dysfunction: a randomized controlled study. Lancet 2001;357:587-591.
24. Halloran P, Mathew T, Tomlanovich S, et al. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. Transplantation 1997;63:39-47.
25. Eckhoff D, McGuire B, Frenette L, et al. Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation. Transplantation 1998;65:180-187.
26. Kaufman D, Leventhal J, Stuart J, et al. Mycophenolate mofetil and tacrolimus as primary maintenance immuno-suppression in simultaneous pancreas-kidney transplantation. Transplantation 1999;67:586-593.
27. Meiser BM, Pfeiffer M, Schmidt D, et al. Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring. J Heart Lung Transplant 1999;18:143-149.
28. Jain A, Kashyap R, Dodson F, et al. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report. Transplantation 2001;72:1091-1097.
29. Yoshida S, Toyama Y, Aoki T, et al. Combination therapy with FK506 and RS61443 for rejection following allogeneic small bowel transplantation in rats. Transplant Proc 2000;32:2492-2493.